Polymerase Chain Reaction Technology Market Report 2024 (Global Edition)

Global Polymerase Chain Reaction Technology Market Report 2024 Market Size Split by Product (Reagents & Consumables, Instruments, Software, Services), by Technique (Conventional PCR, Real-time PCR, Di...

Polymerase Chain Reaction Technology Market Report Description

We have various report editions of Polymerase Chain Reaction Technology Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Polymerase Chain Reaction Technology Market Insights Video

Competitive Landscape of the Polymerase Chain Reaction Technology Market

The PCR technology market is highly competitive, with key players dominating through extensive product portfolios, advanced R&D capabilities, and strong global distribution networks. Emerging players and regional firms also contribute to market dynamics, focusing on innovation and cost-effective solutions. Intense competition drives continuous advancements, impacting pricing strategies and fostering the development of next-generation PCR technologies.

November 2023: F. Hoffmann-La Roche Ltd introduced LightCycler PRO System – a new next-generation qPCR system to enhance molecular diagnostics clinical needs. (Source:https://diagnostics.roche.com/global/en/news-listing/2023/roche-launches-next-generation-qpcr-system-to-advance-clinical-needs.htmlhttps://ir.amkor.com/news-releases/news-release-details/amkor-technology-signs-commitment-science-based-targets) November 2022: PCR Biosystems launched a new family of qPCR reagent mixes: Clara Probe Mix, Clara Probe 1-Step Mix, and Clara HRM Mix. (Source: https://pcrbio.com/row/blog/2022/11/09/next-generation-of-qpcr-reagents-push-the-boundaries-of-performance/)

Top Companies Market Share in Polymerase Chain Reaction Technology Industry: (In no particular order of Rank)

• Thermo Fisher Scientific Inc
• Danaher
• Abbott
• Bio-Rad Laboratories
• Inc.
• Agilent Technologies
• Inc.
• QIAGEN
• F. Hoffmann-La Roche Ltd.
• Stilla
• Standard BioTools
• Microsynth AG
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Polymerase Chain Reaction Technology Market

Which Region Dominates the Polymerase Chain Reaction Technology Market in 2024?

According to Cognitive Market Research, North America dominated the market in the year 2024. It accounted for around 40% of global revenue due to its advanced healthcare infrastructure, strong presence of leading biotech firms, and high investment in research and development. The region's focus on personalized medicine, robust regulatory framework, and widespread adoption of cutting-edge diagnostic technologies further solidify its leadership position.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Polymerase Chain Reaction Technology market due to increasing healthcare investments, rising prevalence of infectious diseases, and expanding research activities. Rapid advancements in medical infrastructure and government initiatives to enhance diagnostic capabilities further drive the region's strong market growth.

The current report Scope analyzes Polymerase Chain Reaction Technology Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Polymerase Chain Reaction Technology Market

According to Cognitive Market Research, the global Polymerase Chain Reaction Technology market size was estimated at USD 14251.6 Million, out of which North America held the major market share of more than 40% of global revenue with a market size of USD 5700.64 million in 2024 and will rise at the compound annual growth rate (CAGR) of 6.7% from the year 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Polymerase Chain Reaction Technology market with a market size of USD 4497.80 million in 2024 and is foreseen to rise at a CAGR of 6.5% during the forecast years due to the high demand for advanced diagnostics.
• The Canada Polymerase Chain Reaction Technology market had a market share of USD 684.08 million in 2024 and is foreseen to rise at a CAGR of 7.5% during the forecast years due to the increasing demand for advanced diagnostics, research applications, and personalized medicine.
• The Mexico Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 7.2% during the forecast years, with a market size of USD 518.76 million in 2024.

Europe Polymerase Chain Reaction Technology Market

According to Cognitive Market Research, the global Polymerase Chain Reaction Technology market size was estimated at USD 14251.6 Million, out of which Europe held the market share of more than 30% of global revenue with the market size of USD 4275.48 million in 2024 and will rise at the compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• The United Kingdom Polymerase Chain Reaction Technology market had the market share of USD 718.28 million in 2024 and is foreseen to rise at the CAGR of 7.8% during the forecast years. In the UK, Polymerase Chain Reaction Technology sales witness an upswing due to a robust healthcare system, high demand for advanced diagnostics, and extensive research initiatives in genomics and infectious diseases.
• The France Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 6.2% during the forecast years, with a market size of USD 393.34 million in 2024.
• According to Cognitive Market Research, the German Polymerase Chain Reaction Technology market size was valued at USD 846.55 million in 2024 and is foreseen to rise at a CAGR of 7.2% during the forecast period. In Germany, Polymerase Chain Reaction Technology surged due to the high demand for advanced diagnostics in infectious diseases and oncology.
• The Italy Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 6.4% during the forecast years, with a market size of USD 367.69 million in 2024.
• The Russia Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 6.0% during the forecast years, with a market size of USD 662.70 million in 2024.
• The Spain Polymerase Chain Reaction Technology market is foreseen to experience growth at the CAGR of 6.1% during the forecast years with a market size of USD 350.59 million in 2024
• The Luxembourg Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 7.1% during the forecast years, with a market size of USD 132.54 million in 2024.
• The Portugal Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 6.8% during the forecast years, with a market size of USD 89.79 million in 2024.
• The Greece Polymerase Chain Reaction Technology market is foreseen to experience growth at the CAGR of 7.3% during the forecast years, with the market size of USD 51.31 million in 2024.
• Rest of Europe's Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 5.7% during the forecast years, with a market size of USD 662.70 million in 2024.

Asia Pacific Polymerase Chain Reaction Technology

According to Cognitive Market Research, the global Polymerase Chain Reaction Technology market size was estimated at USD 14251.6 Million, out of which Asia Pacific held the market share of around 23% of global revenue with the market size of USD 3277.87 million in 2024 and will rise at the compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Polymerase Chain Reaction Technology market size was valued at USD 1475.04 million in 2024 and is foreseen to rise at a CAGR of 10.0% during the forecast period. Polymerase Chain Reaction Technology surged in China due to the rapid advancements in healthcare infrastructure.
• The Japan Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 9.0% during the forecast years, with a market size of USD 1475.04 million in 2024.
• The India Polymerase Chain Reaction Technology market had a market share of USD 393.34 million in 2024 and is foreseen to rise at the CAGR of 12.3% during the forecast years due to the increasing demand for accurate diagnostics and government initiatives to enhance healthcare infrastructure.
• The South Korean Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 9.6% during the forecast years, with a market size of USD 327.79 million in 2024.
• The Australian Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 10.2% during the forecast period, with a market size of USD 170.45 million in 2024.
• The South East Asia Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 11.5% during the forecast years, with a market size of USD 226.17 million in 2024.
• The Rest of Asia Pacific Polymerase Chain Reaction Technology market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 232.73 million in 2024.

South America Polymerase Chain Reaction Technology Market

According to Cognitive Market Research, the global Polymerase Chain Reaction Technology market size was estimated at USD 14251.6 Million, out of which Latin America held the market share of around 5% of global revenue with the market size of USD 712.58 million in 2024 and will rise at the compound annual growth rate (CAGR) of 7.9% from the year 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Polymerase Chain Reaction Technology market size was valued at USD 304.98 million in 2024 and is foreseen to rise at the CAGR of 8.5% during the forecast years. Polymerase Chain Reaction Technology flourished in Brazil due to the increasing demand for infectious disease diagnostics.
• Argentina's Polymerase Chain Reaction Technology market had a market share of USD 119.71 million in 2024 and is projected to rise at the CAGR of 8.8% during the forecast years due to the surging demand for modern diagnostic tools to address infectious diseases.
• Colombia Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 7.7% during the forecast years, with a market size of USD 63.42 million in 2024.
• Peru Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 8.1% during the forecast years, with a market size of USD 58.43 million in 2024.
• Chile Polymerase Chain Reaction Technology market is foreseen to experience growth at the CAGR of 8.2% during the forecast years, with a market size of USD 51.31 million in 2024.
• The Rest of Latin America's Polymerase Chain Reaction Technology market is foreseen to experience growth at the CAGR of 7.0% during the forecast years, with the market size of USD 114.73 million in 2024.

Middle East and Africa Polymerase Chain Reaction Technology Market

According to Cognitive Market Research, the global Polymerase Chain Reaction Technology market size was estimated at USD 14251.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 285.03 million in 2024 and will rise at the compound annual growth rate (CAGR) of 8.2% from the year 2024 to 2031..

• The GCC Countries Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 9.0% during the forecast period, with a market size of USD 121.99 million in 2024. Polymerase Chain Reaction Technology sales flourish due to the rising demand for advanced diagnostic tools.
• The Egypt Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 8.5% during the forecast period, with a market size of USD 29.93 million in 2024.
• The South Africa Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 9.2% during the forecast years, with a market size of USD 45.04 million in 2024. Polymerase Chain Reaction Technology sales flourish in South Africa due to the expanding research and diagnostic capabilities.
• The Turkey Polymerase Chain Reaction Technology market is foreseen to experience growth at a CAGR of 7.7% during the forecast years, with a market size of USD 24.51 million in 2024.
• The Nigeria Polymerase Chain Reaction Technology market is foreseen to experience growth at the CAGR of 7.3% during the forecast years, with a market size of USD 29.93 million in 2024.
• The Rest of the MEA Polymerase Chain Reaction Technology market is foreseen to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 33.63 million in 2024.

Polymerase Chain Reaction Technology Market Analysis

Polymerase Chain Reaction Technology Market Product Segment Analysis

According to Cognitive Market Research, reagents & consumables are the dominant category over the projected period due to their essential role in the amplification process. These include enzymes, primers, and buffers, which are critical for accurate and efficient testing. Their frequent use and ongoing need for replenishment ensure a steady demand, driving significant market share in PCR technology.

Software is the fastest-growing category in the Polymerase Chain Reaction Technology market due to its role in enhancing data analysis, automation, and integration with advanced PCR systems. Innovative software solutions improve accuracy, efficiency, and data management, driving increased adoption and growth in the market as laboratories seek more sophisticated analytical tools.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Polymerase Chain Reaction Technology Industry. Request a Free Sample PDF!

Polymerase Chain Reaction Technology Market Technique Segment Analysis

According to Cognitive Market Research, the dominant category is real-time PCR due to its ability to provide rapid, quantitative results with high sensitivity and accuracy. Its applications in diagnostics, research, and personalized medicine, along with advancements in technology, have made it the preferred choice for various molecular biology and clinical testing needs.

The fastest-growing category in the Polymerase Chain Reaction Technology market is digital PCR due to its superior sensitivity, precision, and ability to quantify low-abundance DNA targets with high accuracy. Its advanced technology enables precise measurement of genetic variations and minimal contamination risks, making it increasingly popular in research, clinical diagnostics, and personalized medicine.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Polymerase Chain Reaction Technology End-User Segment Analysis

Polymerase Chain Reaction Technology Market End-User Segment Analysis

According to Cognitive Market Research, the dominant category is hospitals & diagnostic centers due to the high demand for accurate, rapid diagnostic testing. Their extensive use of PCR for disease detection, personalized medicine, and routine diagnostics ensures significant market share, with these facilities investing in advanced PCR systems and technologies for enhanced patient care and diagnostic precision.

The fastest-growing category in the Polymerase Chain Reaction Technology market is pharma-biotech companies due to their increasing focus on drug development, personalized medicine, and genomic research. Their investment in advanced PCR applications for genetic analysis, biomarker discovery, and clinical trials drives rapid growth and innovation in this sector.

• Hospitals and Diagnostic Centers
• Healthcare Industry
• Academia and Government Organizations
• Pharma-Biotech Companies
• Applied Industries
• Others

Polymerase Chain Reaction Technology Application Segment Analysis

Polymerase Chain Reaction Technology Market Application Segment Analysis

According to Cognitive Market Research, the dominant category is diagnostic applications due to their critical role in detecting infectious diseases, genetic disorders, and cancer. The precision, speed, and reliability of PCR make it essential for accurate diagnostics, leading to high demand and substantial market share in clinical and laboratory settings.

The fastest-growing category in the Polymerase Chain Reaction Technology market is genotyping due to its crucial role in personalized medicine, genetic research, and agricultural applications. The increasing demand for precise genetic analysis and advancements in high-throughput genotyping technologies drive rapid market expansion in this area.

• Gene Expression Analysis
• Genetic Sequencing
• Genotyping
• Nucleic Acid Detection
• Nucleic Acid Synthesis
• Diagnostic Applications
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion